NCT03332771 Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy Status COMPLETED Phase PHASE3
NCT03327662 Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer Status TERMINATED Phase PHASE3
NCT03324113 Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT03319667 A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03317015 A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR) Status COMPLETED Phase PHASE3
NCT03315143 Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk Status TERMINATED Phase PHASE3
NCT03312478 Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes Status COMPLETED Phase PHASE4
NCT03310944 Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03293030 Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT03292653 Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart Failure Status TERMINATED Phase PHASE2
NCT03285594 Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents Status COMPLETED Phase PHASE3
NCT03284957 Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03279289 Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen Status COMPLETED Phase PHASE2
NCT03275285 Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients Status COMPLETED Phase PHASE3
NCT03264274 Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT03260868 Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy) Status TERMINATED Phase PHASE4
NCT03242252 Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control Status COMPLETED Phase PHASE3
NCT03242018 A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control Status COMPLETED Phase PHASE3
NCT03236311 A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI Status TERMINATED Phase PHASE2